
Sanofi appoints senior vice president
pharmafile | October 10, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Sanofi, warnery
Vincent Warnery has been appointed as the senior vice president to Sanofi’s new Global Consumer Healthcare Division.
He will remain in Paris and will report to Pascale Witz, executive vice president, Global Divisions and Strategic Commercial Development.
Warnery is now responsible for setting up and leading its new Global CHC Division to co-ordinate new product development, multi-regional commercial strategy and business development.
Warnery joined the firm in 2011 as vice president Consumer Healthcare Europe and Global Development, and has over 20 years’ experience in the consumer business. He started out his career in marketing at Procter & Gamble, then moved to Bacardi before spending 15 years working for L’Oréal.
Warnery has a broad international background and held a number of general management positions in Portugal, Germany, Latin America, Japan and France.
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






